Anchorage Capital Group

Latest statistics and disclosures from Anchorage Capital Group's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are S, DNA, AMBP, AMBP.WS, and represent 100.00% of Anchorage Capital Group's stock portfolio.
  • Reduced shares in these 2 stocks: FYBR (-$89M), ROIV (-$55M).
  • Sold out of its positions in FYBR, ROIV.
  • Anchorage Capital Group was a net seller of stock by $-143M.
  • Anchorage Capital Group has $117M in assets under management (AUM), dropping by -54.62%.
  • Central Index Key (CIK): 0001300714

Tip: Access up to 7 years of quarterly data

Positions held by Anchorage Capital Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Anchorage Capital Group

Anchorage Capital Group holds 4 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Sentinelone Cl A (S) 74.1 $87M 4.9M 17.61
 View chart
Ginkgo Bioworks Holdings Cl A New (DNA) 21.7 $26M 1.7M 14.58
 View chart
Ardagh Metal Packaging S A SHS (AMBP) 4.2 $5.0M 1.3M 3.99
 View chart
Ardagh Metal Packaging S A *w Exp 08/04/202 (AMBP.WS) 0.0 $16k 1.2M 0.01
 View chart

Past Filings by Anchorage Capital Group

SEC 13F filings are viewable for Anchorage Capital Group going back to 2010

View all past filings